Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1Phase 1 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 68Thoracic 29Head & Neck 25Breast 18Gynecologic 17Genitourinary 15Dermatologic 11Other solid neoplasm 5Sarcoma 3Lymphoid 1CNS 1

Conditions

Glioblastoma 527Brain Neoplasms 414Glioma 342Astrocytoma 239Central Nervous System Neoplasms 201Neuroblastoma 195Gliosarcoma 163Oligodendroglioma 149Medulloblastoma 118Neoplasms 113Ependymoma 72Recurrence 70Breast Neoplasms 69Sarcoma 65Melanoma 62Carcinoma, Non-Small-Cell Lung 58Osteosarcoma 57Diffuse Intrinsic Pontine Glioma 48Wilms Tumor 47Familial ependymoma 47Lymphoma 46Neoplasm Metastasis 45Optic Nerve Glioma 44Rhabdomyosarcoma 42Rhabdoid Tumor 42Lung Neoplasms 42Choroid Plexus Neoplasms 42Neuroectodermal Tumors, Primitive 38Meningeal Carcinomatosis 38Ovarian Neoplasms 37

Interventions

adavosertib 1Radiotherapy 1Radiation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Esophageal Squamous Cell Carcinoma × CNS × Clear all
NCT04460937 2026-04-29

Testing the Addition of an Anti-cancer Drug, Adavosertib, to Radiation Therapy for Patients With Incurable Esophageal and Gastroesophageal Junction Cancers

National Cancer Institute (NCI)

Phase 1 Active not recruiting
4 enrolled 9 charts
CNSGastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma, Brain Neoplasms, Meningeal Carcinomatosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡